Skip to content

The Effects of sodium butyrate supplementation on obesity

The Effects of butyrate supplementation on plasma atherogenic index(AIP), serum level of hsCRP, expression level of adiponectin receptors(AdipoR1& R2), AMP activated protein kinase(AMPK) and uncoupling proteins(UCP2&3) genes in Obese individuals on a weight loss diet: A Randomized, Triple- Blind, Placebo- Controlled Clinical Trial

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT20190303042905N3
Enrollment
50
Registered
2021-06-22
Start date
2021-06-27
Completion date
Unknown
Last updated
2021-07-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity. Obesity due to excess calories

Interventions

Intervention 1: Intervention group: one butyrate capsule of 600mg/day(made by Body Bio company, USA, containing 550 mg of butyrate and 50 mg sodium hydroxide, medium-chain triglycerides (MCT), hydroxy

Sponsors

Tabriz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Body mass index (BMI) between 30-40 Both of genders female and male Age between 18-60 years old

Exclusion criteria

Exclusion criteria: Unwillingness to participate in the study Kidney diseases liver failure heart failure rheumatic diseases diabetes malignancies, and gastrointestinal diseases Taking weightloss drugs and following a weight loss diet History of bariatric surgery Smoking Pregnancy, lactation, menopause

Design outcomes

Primary

MeasureTime frame
Gene expression level of AdipoR1& R2. Timepoint: Before the intervention and two months after the intervention. Method of measurement: Real- time PCR.;Gene expression level of AMPK. Timepoint: Before the intervention and two months after the intervention. Method of measurement: Real- time PCR.;Gene expression level of UCP 2 & 3. Timepoint: Before the intervention and two months after the intervention. Method of measurement: Real- time PCR.

Secondary

MeasureTime frame
Serum levels of hsCRP. Timepoint: Before the intervention and two months after the intervention. Method of measurement: ELISA kit.;Atherogenic index of plasma(AIP). Timepoint: Before the intervention and two months after the intervention. Method of measurement: based on formula: AIP=log??triglycerides /high density lipoprotein?.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactParichehr Amiri

Ahvaz University of Medical Sciences

amiriparichehr70@gmail.com+98 21 4568 9745

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026